Wellness99.1% verified
Move cursor to rotate · 3D render
Wellness · Compound
PT-141 (Bremelanotide)
CAS
189691-06-3
Dose
10mg per vial
Formula
C₅₀H₆₈N₁₄O₁₀
MW
1025.18 g/mol
Batch
PX-2026-0129
Purity
99.1%
Melanocortin receptor agonist. Studied in sexual function and central nervous system pathway research.
Per vial · CAD
CAD $59
Selected
10mg per vial
Lyophilized · ambient-stable · In stock
Batch PX-2026-0129 →Research use only. Not for diagnostic, therapeutic, or human-consumption use.
Buying in volume? US and UK wholesale handled by direct contact — custom rates by monthly order volume.
Apply to the wholesale program Production COA
Per batch
Verification
3rd party
Form
Lyophilized
Current batch
The chromatogram for this vial.
Batch PX-2026-0129 · HPLC trace
PT-141 (Bremelanotide)
Purity
99.1%
Produced
2026-02-22
Verified
2026-02-26
Signed by Independent third-party lab · 2026-02-26Hover the peaks to inspect retention times
Overview
About the compound.
PT-141 (Bremelanotide) is a cyclic heptapeptide and a non-selective melanocortin receptor agonist with central nervous system activity, including MC4-mediated pathways. It is the subject of ongoing sexual function research and was the active in the Phase 3 RECONNECT trials for hypoactive sexual desire disorder. Production batch came back at 99.1% purity by HPLC.
Research contexts
Melanocortin receptor researchSexual function studies
Batch history
Every batch we’ve ever sent out.
Adjacent research
Compounds that pair with PT-141 (Bremelanotide).
Metabolic99.1% verified
CAS 2381089-83-2
C₂₁₄H₃₃₃N₅₀O₆₅
GLP-3 (Retatrutide)
5mg per vial · Batch PX-2026-0142
From CAD $129
per vial · CAD
Longevity99.0% verified
CAS 53-84-9
C₂₁H₂₇N₇O₁₄P₂
NAD+
500mg per vial · Batch PX-2026-0138
CAD $149
per vial · CAD
Recovery98.9% verified
CAS Blend
BPC-157 · TB-500 · GHK-Cu · KPV
KLOW
50mg blend per vial · Batch PX-2026-0133
CAD $219
per vial · CAD
10mg per vial
CAD $59